Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Tips to minimize risk of bug bites and related illnesses

While the image of a bug crawling on your arm or a creepy crawler snuggling up in your bed is enough to make you flinch, most bug bites are harmless and disappear on their own in a matter of days. Other insects, however, can spread disease and cause severe reactions that require medical attention.

4 Aug 2011

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

The U.S. Food and Drug Administration today approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

4 Aug 2011

Dangers of colon cleansing: More harm than good

According to a new study released today in the Journal of Family Practice colon cleaning may be harmful. Researchers from Georgetown University Medical School looked at 20 studies published in the last decade and found little evidence of benefit to colon cleansing. But they did find dozens of cases of problems: cramping, bloating, vomiting, electrolyte imbalance, renal failure, and even death.

1 Aug 2011

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be available as a generic in 100 milligrams per 5 mL (20 milligrams per 1 mL).

1 Aug 2011

Colon cleansing can cause side effects like cramping, renal failure and death

Colon cleansing - it's been described as a natural way to enhance well-being, but Georgetown University doctors say there's no evidence to back that claim. In fact, their review of scientific literature, published today in the August issue of The Journal of Family Practice, demonstrates that colon cleansing can cause side effects ranging from cramping to renal failure and death.

1 Aug 2011

PA departments warn public regarding use of glass-bottled milk from Brunton Dairy in Aliquippa

The Pennsylvania departments of Health and Agriculture and the Allegheny County Health Department are advising the public of the possible health risks associated with products, specifically glass-bottled milk, from Brunton Dairy in Aliquippa, Beaver County.

30 Jul 2011

Cancer patients should stick to basic sun-protection guidelines, experts say

Summer often brings with it fun in the sun, but for cancer patients it also presents new challenges and the need for additional protection.

30 Jul 2011

Cadence confirms FDA dosing recommendations for OFIRMEV

Cadence Pharmaceuticals, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg.

29 Jul 2011

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.

29 Jul 2011

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes.

28 Jul 2011

Extreme heat and rain lead to higher mold count in the Midwest

A record 7 inches of rain combined with the spate of 100-plus-degree days has spawned the highest mold count recorded for the year, just short of an air pollution warning.

27 Jul 2011

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Otsuka Canada Pharmaceutical Inc. (OCPI) announced today that Health Canada has issued a notice of compliance for SAMSCA (tolvaptan), the first medicine approved in Canada for the treatment of hyponatremia.

27 Jul 2011

Fluoride supplements neither safe or effective

Sodium fluoride supplements "have not been found by FDA to be safe or effective," according to the U.S. National Library of Medicine's website, reports the New York State Coalition Opposed to Fluoridation, Inc..

25 Jul 2011

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

Baxter International Inc. announced today that the U.S. Food and Drug Administration has approved the subcutaneous administration of GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] for patients with primary immunodeficiency.

From Baxter International Inc. 25 Jul 2011

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

BioDelivery Sciences International, Inc. announced today that the last patient has completed the randomized portion of its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain, signifying completion of the trial.

25 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its supplemental Biologics License Application (sBLA) for SIMPONI.

25 Jul 2011

Cholera hits Haiti again

Cholera the bacterial disease that rapidly leads to diarrhea and dehydration and kills millions worldwide ravaged Haiti last fall and has spread quickly to all regions of the Caribbean country. With the rainy season now in progress, clinics across the country are again bustling with seriously ill patients.

24 Jul 2011

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Cephalon, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA and ACTIQ.

22 Jul 2011

Loyola medical experts offer heat and pollution advisory prescriptions

Many across the nation are experiencing the "dog days of summer" and medical experts at Gottlieb Memorial Hospital, part of Loyola University Health System, warn residents to take extra precautions to safeguard their health.

21 Jul 2011

Vomiting News and Research

Further Reading

Tips to minimize risk of bug bites and related illnesses

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

Dangers of colon cleansing: More harm than good

FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients

Colon cleansing can cause side effects like cramping, renal failure and death

PA departments warn public regarding use of glass-bottled milk from Brunton Dairy in Aliquippa

Cancer patients should stick to basic sun-protection guidelines, experts say

Cadence confirms FDA dosing recommendations for OFIRMEV

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Extreme heat and rain lead to higher mold count in the Midwest

Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia

Fluoride supplements neither safe or effective

Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration

BDSI completes BEMA Buprenorphine Phase 3 trial on chronic pain

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Cholera hits Haiti again

FDA approves Cephalon's REMS for FENTORA, ACTIQ

Loyola medical experts offer heat and pollution advisory prescriptions

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News